Epidemiology of Guillain-Barré syndrome in Aruba

American Journal of Tropical Medicine and Hygiene

Volumn 94, Issue 6, 2016, Pages 1380-1384

  Suryapranata, Franciska S T ^a   Ang, C Wim ^a   Chong, Luis L ^b   Murk, Jean Luc ^c   Falconi, Jaime ^d   Huits, Ralph M H G ^e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Landslaboratorium ^*  (Aruba)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Dr Horacio E Oduber Hospital   (Aruba)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; GANGLIOSIDE GM1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; ARUBA; CAMPYLOBACTER ENTERITIS; CARIBBEAN ISLANDS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRANIAL NERVE PARALYSIS; CYTOMEGALOVIRUS INFECTION; DENGUE; EPSTEIN BARR VIRUS INFECTION; FEMALE; GUILLAIN BARRE SYNDROME; HOSPITAL PATIENT; HUMAN; IMMOBILITY; INCIDENCE; MALE; MEDICAL RECORD REVIEW; MORTALITY; MYCOPLASMA PNEUMONIA; SEROLOGY; WEAKNESS; WEST NILE FEVER; GUILLAIN-BARRE SYNDROME; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDY; SEASON; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DENGUE; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; SEASONS; YOUNG ADULT;

EID: 84971520459     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.15-0070     Document Type: Article

References (27)

1. McGrogan A, Madle GC, Seaman HE, deVries CS, 2009. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology 32: 150-163.
2. Alter M, 1990. The epidemiology of Guillain-Barré syndrome. Ann Neurol 27 (Suppl): S7-S12.
3. Govoni V, Granieri E, 2001. Epidemiology of the Guillain-Barré syndrome. Curr Opin Neurol 14: 605-613.
4. VanKoningsveld R, VanDoorn PA, Schmitz PI, Ang CW, VanderMeche FG, 2000. Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology 54: 620-625.
5. Hughes RA, Cornblath DR, 2005. Guillain-Barré syndrome. Lancet 366: 1653-1666.
6. Hughes RA, Rees JH, 1997. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 176 (Suppl 2): S92-S98.
7. Rees JH, Soudain SE, Gregson NA, Hughes RA, 1995. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 333: 1374-1379.
8. Jacobs BC, Rothbarth PH, vanderMeche FG, Herbrink P, Schmitz PI, deKlerk MA, vanDoorn PA, 1998. The spectrum of antecedent infections in Guillain-Barré syndrome: A casecontrol study. Neurology 51: 1110-1115.
9. Visser LH, van der Meche FG, Meulstee J, Rothbarth PP, Jacobs BC, Schmitz PI, vanDoorn PA, 1996. Cytomegalovirus infection and Guillain-Barre syndrome: The clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barre Study Group. Neurology 47: 668-673.
10. Orlikowski D, Porcher R, Sivadon-Tardy V, Quincampoix JC, Raphael JC, Durand MC, Sharshar T, Roussi J, Caudie C, Annane D, Rozenberg F, Leruez-Ville M, Gaillard JL, Gault E, 2011. Guillain-Barré syndrome following primary cytomegalovirus infection: A prospective cohort study. Clin Infect Dis 52: 837-844.
11. Susuki K, Odaka M, Mori M, Hirata K, Yuki N, 2004. Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry. Neurology 62: 949-956.
12. Ratnam I, Leder K, Black J, Torresi J, 2013. Dengue fever and international travel. J Travel Med 20: 384-393.
13. Puccioni-Sohler M, Soares CN, Papaiz-Alvarenga R, Castro MJ, Faria LC, Peralta JM, 2009. Neurologic dengue manifestations associated with intrathecal specific immune response. Neurology 73: 1413-1417.
14. Sejvar JJ, Leis AA, Stokic DS, Van Gerpen JA, Marfin AA, Webb R, Haddad MB, Tierney BC, Slavinski SA, Polk JL, Dostrow V, Winkelmann M, Petersen LR, 2003. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 9: 788-793.
15. Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ, 2000. Neurological manifestations of dengue infection. Lancet 355: 1053-1059.
16. VanKoningsveld R, Rico R, Gerstenbluth I, Schmitz PI, Ang CW, Merkies IS, Jacobs BC, Halabi Y, Endtz HP, VanderMeche FG, VanDoorn PA, 2001. Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean island Curacao. Neurology 56: 1467-1472.
17. Asbury AK, Cornblath DR, 1990. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27 (Suppl): S21-S24.
18. Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M, 2011. Guillain-Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29: 599-612.
19. Vucic S, Kiernan MC, Cornblath DR, 2009. Guillain-Barré syndrome: An update. J Clin Neurosci 16: 733-741.
20. Govoni V, Granieri E, Tola MR, Casetta I, Ruppi P, Vaghi L, 1999. The frequency of clinical variants of Guillain-Barre syndrome in Ferrara, Italy. J Neurol 246: 1010-1014.
21. Arami MA, Yazdchi M, Khandaghi R, 2006. Epidemiology and characteristics of Guillain-Barré syndrome in the northwest of Iran. Ann Saudi Med 26: 22-27.
22. Rocha MS, Brucki SM, Carvalho AA, Lima UW, 2004. Epidemiologic features of Guillain-Barré syndrome in Sao Paulo, Brazil. Arq Neuropsiquiatr 62: 33-37.
23. Jiang GX, Cheng Q, Link H, de Pedro-Cuesta J, 1997. Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-93. J Neurol Neurosurg Psychiatry 62: 447-453.
24. Leslie T, Martin NJ, Jack-Roosberg C, Odongo G, Beausoleil E, Tuck J, Raviprakash K, Kochel TJ, 2014. Dengue serosurvey in Sint Eustatius. PLoS One 9: E95002.
25. Soares CN, Faria LC, Peralta JM, de Freitas MR, Puccioni- Sohler M, 2006. Dengue infection: Neurological manifestations and cerebrospinal fluid (CSF) analysis. J Neurol Sci 249: 19-24.
26. PAHO, 2003-2011. Number of Reported Cases of Dengue and Dengue Hemorrhagic Fever in the Americas, by Country. Washington, DC: PAHO.
27. vanKoningsveld R, Steyerberg EW, Hughes RA, Swan AV, vanDoorn PA, Jacobs BC, 2007. A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet Neurol 6: 589-594.